208 related articles for article (PubMed ID: 34710720)
1. Risk of malignancy in patients with systemic lupus erythematosus: Systematic review and meta-analysis.
Clarke AE; Pooley N; Marjenberg Z; Langham J; Nicholson L; Langham S; Embleton N; Wang X; Desta B; Barut V; Hammond ER
Semin Arthritis Rheum; 2021 Dec; 51(6):1230-1241. PubMed ID: 34710720
[TBL] [Abstract][Full Text] [Related]
2. Systemic lupus erythematous and malignancy risk: a meta-analysis.
Cao L; Tong H; Xu G; Liu P; Meng H; Wang J; Zhao X; Tang Y; Jin J
PLoS One; 2015; 10(4):e0122964. PubMed ID: 25885411
[TBL] [Abstract][Full Text] [Related]
3. Systemic lupus erythematosus; stroke and myocardial infarction risk: a systematic review and meta-analysis.
Yazdany J; Pooley N; Langham J; Nicholson L; Langham S; Embleton N; Wang X; Desta B; Barut V; Hammond E
RMD Open; 2020 Sep; 6(2):. PubMed ID: 32900883
[TBL] [Abstract][Full Text] [Related]
4. Lung, liver, prostate, bladder malignancies risk in systemic lupus erythematosus: evidence from a meta-analysis.
Ni J; Qiu LJ; Hu LF; Cen H; Zhang M; Wen PF; Wang XS; Pan HF; Ye DQ
Lupus; 2014 Mar; 23(3):284-92. PubMed ID: 24429300
[TBL] [Abstract][Full Text] [Related]
5. Systemic lupus erythematosus and malignancies risk.
Mao S; Shen H; Zhang J
J Cancer Res Clin Oncol; 2016 Jan; 142(1):253-62. PubMed ID: 26319223
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular events and risk in patients with systemic lupus erythematosus: Systematic literature review and meta-analysis.
Bello N; Meyers KJ; Workman J; Hartley L; McMahon M
Lupus; 2023 Mar; 32(3):325-341. PubMed ID: 36547368
[TBL] [Abstract][Full Text] [Related]
7. Patients with asthma have a higher risk of systemic lupus erythematosus: a systematic review and meta-analysis.
Charoenngam N; Ponvilawan B; Wongtrakul W; Ungprasert P
Clin Rheumatol; 2021 Feb; 40(2):529-536. PubMed ID: 32638252
[TBL] [Abstract][Full Text] [Related]
8. Antimalarials may reduce cancer risk in patients with systemic lupus erythematosus: a systematic review and meta-analysis of prospective studies.
Li XB; Cao NW; Chu XJ; Zhou HY; Wang H; Yu SJ; Ye DQ; Li BZ
Ann Med; 2021 Dec; 53(1):1687-1695. PubMed ID: 34553648
[TBL] [Abstract][Full Text] [Related]
9. Correlation between systemic lupus erythematosus and malignancies: a cross-sectional population-based study.
Azrielant S; Tiosano S; Watad A; Mahroum N; Whitby A; Comaneshter D; Cohen AD; Amital H
Immunol Res; 2017 Apr; 65(2):464-469. PubMed ID: 28091805
[TBL] [Abstract][Full Text] [Related]
10. Risk of malignancy in an unselected cohort of Icelandic patients with systemic lupus erythematosus.
Ragnarsson O; Gröndal G; Steinsson K
Lupus; 2003; 12(9):687-91. PubMed ID: 14514131
[TBL] [Abstract][Full Text] [Related]
11. The risk of infections in adult patients with systemic lupus erythematosus: systematic review and meta-analysis.
Pego-Reigosa JM; Nicholson L; Pooley N; Langham S; Embleton N; Marjenberg Z; Barut V; Desta B; Wang X; Langham J; Hammond ER
Rheumatology (Oxford); 2021 Jan; 60(1):60-72. PubMed ID: 33099651
[TBL] [Abstract][Full Text] [Related]
12. Increased cancer risk in patients with cutaneous lupus erythematosus and systemic lupus erythematosus compared with the general population: A Danish nationwide cohort study.
Westermann R; Zobbe K; Cordtz R; Haugaard JH; Dreyer L
Lupus; 2021 Apr; 30(5):752-761. PubMed ID: 33497306
[TBL] [Abstract][Full Text] [Related]
13. Is there an association of malignancy with systemic lupus erythematosus? An analysis of 276 patients under long-term review.
Sultan SM; Ioannou Y; Isenberg DA
Rheumatology (Oxford); 2000 Oct; 39(10):1147-52. PubMed ID: 11035137
[TBL] [Abstract][Full Text] [Related]
14. Increased risk of malignancy in patients with systemic lupus erythematosus: population-based cohort study in Korea.
Han JY; Kim H; Jung SY; Jang EJ; Cho SK; Sung YK
Arthritis Res Ther; 2021 Oct; 23(1):270. PubMed ID: 34706772
[TBL] [Abstract][Full Text] [Related]
15. Malignancies in systemic lupus erythematosus: an update.
Ladouceur A; Clarke AE; Ramsey-Goldman R; Bernatsky S
Curr Opin Rheumatol; 2019 Nov; 31(6):678-681. PubMed ID: 31403485
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of cervical HPV infection in women with systemic lupus erythematosus: A systematic review and meta-analysis.
García-Carrasco M; Mendoza-Pinto C; Rojas-Villarraga A; Molano-González N; Vallejo-Ruiz V; Munguía-Realpozo P; Colombo AL; Cervera R
Autoimmun Rev; 2019 Feb; 18(2):184-191. PubMed ID: 30572140
[TBL] [Abstract][Full Text] [Related]
17. The risks of cancer development in systemic lupus erythematosus (SLE) patients: a systematic review and meta-analysis.
Song L; Wang Y; Zhang J; Song N; Xu X; Lu Y
Arthritis Res Ther; 2018 Dec; 20(1):270. PubMed ID: 30522515
[TBL] [Abstract][Full Text] [Related]
18. Risk of gestational diabetes mellitus in systemic lupus erythematosus pregnancy: a systematic review and meta-analysis.
Dong Y; Dai Z; Wang Z; Wang H; Yuan F; Zhu Y; Ye D; Wang B
BMC Pregnancy Childbirth; 2019 May; 19(1):179. PubMed ID: 31113392
[TBL] [Abstract][Full Text] [Related]
19. Systemic lupus erythematosus increases risk of incident atrial fibrillation: A systematic review and meta-analysis.
Chen Y; Fu L; Pu S; Xue Y
Int J Rheum Dis; 2022 Oct; 25(10):1097-1106. PubMed ID: 35906745
[TBL] [Abstract][Full Text] [Related]
20. Malignancy in Systemic Lupus Erythematosus (SLE) Patients.
Cader RA; Mei Yee AK; Yassin A; Ahmad I; Haron SN
Asian Pac J Cancer Prev; 2018 Dec; 19(12):3551-3555. PubMed ID: 30583682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
